Cargando…
Diabetic Kinome Inhibitors—A New Opportunity for β-Cells Restoration
Diabetes, and several diseases related to diabetes, including cancer, cardiovascular diseases and neurological disorders, represent one of the major ongoing threats to human life, becoming a true pandemic of the 21st century. Current treatment strategies for diabetes mainly involve promoting β-cell...
Autores principales: | Pucelik, Barbara, Barzowska, Agata, Dąbrowski, Janusz M., Czarna, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396662/ https://www.ncbi.nlm.nih.gov/pubmed/34445786 http://dx.doi.org/10.3390/ijms22169083 |
Ejemplares similares
-
DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets
por: Pucelik, Barbara, et al.
Publicado: (2023) -
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
por: Barzowska, Agata, et al.
Publicado: (2021) -
Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics
por: Pustelny, Katarzyna, et al.
Publicado: (2023) -
Photodynamic Inactivation of Bacteria with Porphyrin Derivatives: Effect of Charge, Lipophilicity, ROS Generation, and Cellular Uptake on Their Biological Activity In Vitro
por: Sułek, Adam, et al.
Publicado: (2020) -
Synthesis
and Characterization of Size- and Charge-Tunable
Silver Nanoparticles for Selective Anticancer and Antibacterial Treatment
por: Pucelik, Barbara, et al.
Publicado: (2022)